| EyePoint Pharmaceuticals, Inc. | |
| Former Name: | pSivida Corp. |
| Type: | Public company |
| Traded As: | NASDAQ: |
| Industry: | Pharmaceuticals |
| Predecessors: | --> |
| Successors: | --> |
| Founders: | --> |
| Hq Location City: | Watertown, Massachusetts |
| Hq Location Country: | USA |
| Num Locations: | 2 |
| Areas Served: | --> |
| Products: | Iluvien |
| Profit: | --> |
| Profit Year: | --> |
| Owners: | --> |
EyePoint Pharmaceuticals Inc. (formerly pSivida Corporation) is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency (DERA, now QinetiQ). QinetiQ continues to be a strategic partner.[1] [2]
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience.[3] [4] Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc.[5]